Maja Noman graduated as MD in 1999 at the Catholic University of Leuven, Belgium. She started as clinical trial physician in the IBD clinical trial team in 1999 under supervision of Paul Rutgeerts. In 2003 she was first co-author of the manuscript entitled “Influence of immunogenicity on the long term efficacy of infliximab in Crohn’s disease” published in New England Journal of Medicine. She participated as co-investigator in more than 100 investigator-initiated and pharma-sponsored clinical trials (phase 1 to phase 4). She currently leads the IBD clinical trial team.